Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers.
肺癌中表皮生长因子受体基因的临床和生物学特点。
Once a gene has accumulated enough mutations, it becomes a “pseudogene,” notes geneticist Doron Lancet of Israel’s Weizmann Institute of Science, meaning it no longer encodes a functioning receptor.
当一个基因变异足够累积，会变成“假基因”，这意味着它无法再为有效感受器编码。
Objective: to characterize the clinical features of Chinese HNPCC families and to screen the mutations of a poly (a) 8 tract in M3 cholinergic receptor gene in these families.
目的：分析中国人遗传性非息肉病性大肠癌(HNPCC)家系的临床特征并检测这些家系中M3胆碱能受体基因(A)8区的突变情况。
Clinicopathologic Significance of the Mutations of the Epidermal Growth Factor Receptor Gene in Patients with Non-Small Cell Lung Cancer.
非小细胞肺癌病人的表皮生长因子受体基因突变的临床病理意义。
This is the first FDA-approved, blood-based genetic test that can detect epidermal growth factor receptor (EGFR) gene mutations in non-small cell lung cancer patients.
这是FDA批准的首个能够检测非小细胞肺癌患者表皮生长因子受体(EGFR)基因突变的、以血液为基础的基因检测试剂盒。
This is the first FDA-approved, blood-based genetic test that can detect epidermal growth factor receptor (EGFR) gene mutations in non-small cell lung cancer patients.
这是FDA批准的首个能够检测非小细胞肺癌患者表皮生长因子受体(EGFR)基因突变的、以血液为基础的基因检测试剂盒。
应用推荐